Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
NM-002 by Novabiotics for Community Acquired Pneumonia: Likelihood of Approval
NM-002 is under clinical development by Novabiotics and currently in Phase III for Community Acquired Pneumonia. According to GlobalData, Phase...